Replies to post #169331 on Amarin Corp Plc (AMRN)

[Jt0082]

The primary endpoint was significantly lower with icosapent ethyl in the secondary prevention cohort (71% of participants) but not in the smaller primary prevention cohort (NEJM JW Gen Med Jan 1 2019 and N Engl J Med 2018 Nov 10; [e-pub]).

But NOT in the smaller primary prevention cohort....what? really ? What devil in the detail am I missing....anyone?